Lund Systemic Sclerosis Research Group
11 – 20 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Survival in Swedish patients with systemic sclerosis : A nationwide population-based matched cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Response to : Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Development and validation of a patient-reported outcome measure for systemic sclerosis : the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
(
- Contribution to journal › Article
-
Mark
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
(
- Contribution to journal › Article
-
Mark
N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis
(
- Contribution to journal › Article
-
Mark
Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study
(
- Contribution to journal › Article
-
Mark
Atrioventricular plane displacement and regional function to predict outcome in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis
(
- Contribution to journal › Article